In order to gain insight in the interaction between enteropathy and lung function in CF and its chronology, serum I-FABP, faecal calprotectin, nutritional status, and lung function should be evaluated simultaneously at frequent intervals in a prospective study, taking into account pulmonary exacerbations. The gene discussed is FABP2; the disease is Abnormal intestine morphology.